2 options
Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office).
Connect to full text Available online
View online- Format:
- Book
- Government document
- Author/Creator:
- United States. Congress. House. Committee on Energy and Commerce, author.
- Series:
- United States. Congress. House. Report ; 116-46.
- Report / 116th Congress, 1st session, House of Representatives ; 116-46
- Language:
- English
- Subjects (All):
- Pharmaceutical industry--United States--Quality control.
- Pharmaceutical industry.
- Generic drugs--Standards--United States.
- Generic drugs.
- Generic drugs--Effectiveness--United States.
- Generic drugs--Prices.
- Drugs--United States--Cost effectiveness.
- Drugs.
- Drugs--Cost effectiveness.
- Generic drugs--Standards.
- Pharmaceutical industry--Quality control.
- United States.
- Genre:
- legislative records.
- Legislative materials.
- Physical Description:
- 1 online resource (59 pages).
- Place of Publication:
- [Washington, D.C.] : [U.S. Government Publishing Office], [2019]
- Notes:
- "May 2, 2019."
- Description based on online resource, PDF version; title from title page (govinfo, viewed July 8, 2019).
- Includes bibliographical references.
- Other Format:
- Microfiche version: United States. Congress. House. Committee on Energy and Commerce. Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019
- Print version: United States. Congress. House. Committee on Energy and Commerce. Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019
- OCLC:
- 1107669191
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.